Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Nat Methods ; 19(10): 1208-1220, 2022 10.
Article in English | MEDLINE | ID: mdl-35618955

ABSTRACT

Circular RNAs (circRNAs) are formed in all domains of life and via different mechanisms. There has been an explosion in the number of circRNA papers in recent years; however, as a relatively young field, circRNA biology has an urgent need for common experimental standards for isolating, analyzing, expressing and depleting circRNAs. Here we propose a set of guidelines for circRNA studies based on the authors' experience. This Perspective will specifically address the major class of circRNAs in Eukarya that are generated by a spliceosome-catalyzed back-splicing event. We hope that the implementation of best practice principles for circRNA research will help move the field forward and allow a better functional understanding of this fascinating group of RNAs.


Subject(s)
RNA, Circular , RNA , RNA/genetics , RNA/metabolism , RNA Splicing
2.
Scand J Work Environ Health ; 45(4): 370-375, 2019 07 01.
Article in English | MEDLINE | ID: mdl-30620377

ABSTRACT

Objectives The aim of this study was to explore Danish cancer survivors perspectives on the process of returning to work. Methods Six focus-group interviews (N=32) were held with cancer survivors attending a five-day rehabilitation stay. Data were analyzed by applying meaning condensation then organized into themes. Results Most cancer survivors do not imagine themselves resuming work in the same way as before they had cancer. Many cancer survivors are missing support when navigating the bureaucracy involved with the process of returning to work and do not know how to become, or when they will be, ready for work. Conclusions Practice guidelines that support Danish cancer survivors in returning to work are currently based on knowledge from international reviews but should be supplemented with elements addressing how and when to become ready for work.


Subject(s)
Cancer Survivors/psychology , Return to Work/psychology , Adult , Age Factors , Denmark , Emotions , Environment , Female , Focus Groups , Humans , Male , Middle Aged , Occupational Stress/epidemiology , Occupational Stress/psychology , Qualitative Research , Sex Factors , Workplace/psychology
3.
J Drug Target ; 18(10): 812-20, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20979442

ABSTRACT

This work presents the novel use of reducible hyperbranched (rHB) polymers for delivery of RNA interference (RNAi) therapeutics. Cationic poly(amido amine) hyperbranched polymers that contain different contents of reducible disulfide to nonreducible linkages (0%, 17%, 25%, and 50%) were used to form interpolyelectrolyte polyplexes with siRNA and precursor miRNA (pre-miRNA). Atomic force microscopy (AFM) revealed rHB complexes of ∼100 nm in size, which exhibited redox-activated disassembly in the presence of dithiothreitol (DTT). The complexes were avidly internalized and showed no cellular toxicity in an endogenous enhanced green fluorescence protein (EGFP) expressing H1299 human lung cancer cell line. The highest specific EGFP gene silencing (∼75%) was achieved with rHB (17%)/siRNA complexes at a weight-to-weight (w/w) ratio of 40 that correlated with the ability for this polymer to successfully transfect pre-miRNA. Evaluation of temporal silencing levels over 72 h revealed incremental knockdown that reached a maximum at 72 h for the rHB (50%) complexes, in contrast to maximum knockdown at 24 h that remained relatively consistent, thereafter, for the rHB (17%), rHB (25%), and non-rHB complexes. The role of particle disassembly for intracellular targeting and modulation of gene silencing addressed in this work are important considerations in the development of this and other next-generation delivery systems.


Subject(s)
Gene Silencing , MicroRNAs/administration & dosage , Polymers/chemistry , RNA, Small Interfering/administration & dosage , Cell Line, Tumor , Electrolytes/chemistry , Gene Expression Regulation, Neoplastic , Gene Knockdown Techniques , Green Fluorescent Proteins/genetics , Humans , Lung Neoplasms/genetics , Microscopy, Atomic Force , Oxidation-Reduction , Polyamines/chemistry , Time Factors , Transfection
4.
Biochemistry ; 49(19): 4103-15, 2010 May 18.
Article in English | MEDLINE | ID: mdl-20387790

ABSTRACT

The hallmark of serpins is the ability to undergo the so-called "stressed-to-relaxed" switch during which the surface-exposed reactive center loop (RCL) becomes incorporated as strand 4 in central beta-sheet A. RCL insertion drives not only the inhibitory reaction of serpins with their target serine proteases but also the conversion to the inactive latent state. RCL insertion is coupled to conformational changes in the flexible joint region flanking beta-sheet A. One interesting serpin is plasminogen activator inhibitor-1 (PAI-1), a fast and specific inhibitor of the serine proteases tissue-type and urokinase-type plasminogen activator. Via its flexible joints' region, native PAI-1 binds vitronectin and relaxed, protease-complexed PAI-1 certain endocytosis receptors. From a library of 35-nucleotides long 2'-fluoropyrimidine-containing RNA oligonucleotides, we have isolated two aptamers binding PAI-1 by the flexible joint region with low nanomolar K(D) values. One of the aptamers exhibited measurable binding to native PAI-1 only, while the other also bound relaxed PAI-1. While none of the aptamers inhibited the antiproteolytic effect of PAI-1, both aptamers inhibited vitronectin binding and the relaxed PAI-1-binding aptamer also endocytosis receptor binding. The aptamer binding exclusively to native PAI-1 increased the half-life for the latency transition to more than 6 h, manyfold more than vitronectin. Contact with Lys124 in the flexible joint region was critical for strong inhibition of the latency transition and the lack of binding to relaxed PAI-1. We conclude that aptamers yield important information about the serpin conformational switch and, because they can compete with high-affinity protein-protein interactions, may provide leads for pharmacological intervention.


Subject(s)
Aptamers, Nucleotide/chemistry , Plasminogen Activator Inhibitor 1/chemistry , Aptamers, Nucleotide/metabolism , Base Sequence , Binding Sites , Crystallography, X-Ray , Humans , Kinetics , Models, Molecular , Molecular Sequence Data , Nucleic Acid Conformation , Plasminogen Activator Inhibitor 1/metabolism , Protein Conformation
5.
Mol Cell ; 35(2): 139-40, 2009 Jul 31.
Article in English | MEDLINE | ID: mdl-19647510

ABSTRACT

A study in this issue of Molecular Cell (Elcheva et al., 2009) shows the inherent instability of the betaTrCP1 mRNA to be caused by microRNA-183 targeting the coding sequence; interestingly, this action is directly opposed by the RNA-binding protein CRD-BP.


Subject(s)
MicroRNAs/physiology , RNA Stability/physiology , RNA, Messenger/metabolism , Argonaute Proteins , Binding Sites , Eukaryotic Initiation Factor-2/metabolism , Humans , MicroRNAs/metabolism , Models, Genetic , RNA, Messenger/chemistry , RNA-Binding Proteins/physiology , beta-Transducin Repeat-Containing Proteins/genetics , beta-Transducin Repeat-Containing Proteins/metabolism
6.
Cell ; 138(2): 224-6, 2009 Jul 23.
Article in English | MEDLINE | ID: mdl-19632172

ABSTRACT

In this issue, Sabin et al. (2009) and Gruber et al. (2009) reveal the protein Ars2 as a versatile regulator of RNA silencing. They show that Ars2 stimulates microRNA processing, contributes to antiviral resistance in flies, and is important for cell proliferation in mammals.


Subject(s)
Nuclear Proteins/metabolism , RNA Cap-Binding Proteins/metabolism , Animals , Cell Survival , Humans , Nuclear Proteins/immunology , RNA Interference
7.
Nucleic Acids Res ; 37(9): 2867-81, 2009 May.
Article in English | MEDLINE | ID: mdl-19282453

ABSTRACT

The use of chemically synthesized short interfering RNAs (siRNAs) is currently the method of choice to manipulate gene expression in mammalian cell culture, yet improvements of siRNA design is expectably required for successful application in vivo. Several studies have aimed at improving siRNA performance through the introduction of chemical modifications but a direct comparison of these results is difficult. We have directly compared the effect of 21 types of chemical modifications on siRNA activity and toxicity in a total of 2160 siRNA duplexes. We demonstrate that siRNA activity is primarily enhanced by favouring the incorporation of the intended antisense strand during RNA-induced silencing complex (RISC) loading by modulation of siRNA thermodynamic asymmetry and engineering of siRNA 3'-overhangs. Collectively, our results provide unique insights into the tolerance for chemical modifications and provide a simple guide to successful chemical modification of siRNAs with improved activity, stability and low toxicity.


Subject(s)
RNA Interference , RNA, Small Interfering/chemistry , Cell Line, Tumor , Cell Survival , Humans , RNA Stability , RNA, Small Interfering/blood , RNA, Small Interfering/toxicity , RNA-Induced Silencing Complex/metabolism
8.
J Gene Med ; 10(1): 81-93, 2008 Jan.
Article in English | MEDLINE | ID: mdl-18000993

ABSTRACT

BACKGROUND: Small interfering RNAs (siRNAs) can induce specific gene silencing through cytoplasmic mRNA cleavage and nuclear transcriptional silencing, necessitating delivery to different cellular compartments. This study presents a reducible copolypeptide (rCPP) carrier containing different molar ratios of a histidine-rich peptide (HRP) and nuclear localization sequence (NLS) peptide to modulate intracellular trafficking of transfected siRNA and primary RNA transcripts (pri-miRNA). METHODS: Polyplex formation using siRNA and rCPP was demonstrated using photon correlation spectroscopy and atomic force microscopy. Confocal and fluorescence microscopy were used to investigate cellular uptake and nuclear trafficking whilst endogenous enhanced green fluorescent protein (EGFP) knockdown in H1299 cells was evaluated using flow cytometry. Transcriptional gene silencing of endogenous EF1A was verified using real-time reverse-transcription polymerase chain reaction (RT-PCR) and pri-miRNA nuclear processing was demonstrated using Northern analysis. RESULTS: rCPP-based polyplexes showed rapid cellular uptake and low cytotoxicity. Labelled components revealed intact polyplexes after 2 h that exhibited directed movements consistent with endosomal trafficking. Polyplex-mediated knockdown of EGFP increased with greater HRP content. The inclusion of NLS promoted nuclear localization of transfected siRNAs and pri-miRNAs to the nuclear compartment allowing for transcriptional silencing of EF1A and Drosha and Dicer dependent expression of mature miRNA, respectively. CONCLUSION: Our results demonstrate that reducible copolypeptides can be used as carriers for the non-toxic cellular delivery of siRNA and pri-miRNA. The nuclear targeting of rCPPs can be utilized for delivery of siRNAs and pri-miRNAs to the nuclear compartment for transcriptional gene silencing or endogenous processing into mature miRNA, respectively, which could potentially lead to improved therapeutic approaches.


Subject(s)
MicroRNAs/metabolism , Peptides/metabolism , RNA Precursors/metabolism , RNA Transport , RNA, Small Interfering/metabolism , Cell Compartmentation , Cell Death/drug effects , Cell Nucleus/drug effects , Cell Nucleus/metabolism , Dithiothreitol/pharmacology , Gene Expression Regulation, Neoplastic/drug effects , HeLa Cells , Humans , MicroRNAs/genetics , Molecular Weight , Oxidation-Reduction/drug effects , Peptides/chemistry , RNA Interference/drug effects , RNA Processing, Post-Transcriptional/drug effects , RNA Transport/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL